Purple Biotech (Purple Biotech) ROE % Adjusted to Book Value : -91.47% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Purple Biotech ROE % Adjusted to Book Value?

Purple Biotech's ROE % for the quarter that ended in Dec. 2023 was -53.05%. Purple Biotech's PB Ratio for the quarter that ended in Dec. 2023 was 0.58. Purple Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -91.47%.

Purple Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Purple Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech ROE % Adjusted to Book Value Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-38.26

-75.12

-23.83

-71.81

-84.52

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-90.13	-52.01	-65.61	-75.17	-91.47

Competitive Comparison of Purple Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Purple Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Purple Biotech's ROE % Adjusted to Book Value falls into.

Purple Biotech ROE % Adjusted to Book Value Calculation

Purple Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-49.02%	/	0.58
	=	-84.52%

Purple Biotech's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-53.05%	/	0.58
	=	-91.47%

Purple Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Purple Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (Purple Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (NAS:PPBT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

PPBT:Israel 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.